Crispr Therapeutics shares owned by Norges Bank Investment Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Norges Bank Investment Management
from 13F filings
Historical chart of Norges Bank Investment Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Norges Bank Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Norges Bank Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $20M | 407k | 48.64 |
| 2024-12-31 | $18M | 444k | 39.36 |
| 2024-09-30 | $19M | 412k | 46.98 |
| 2024-06-30 | $35M | 650k | 54.01 |
| 2024-03-31 | $40M | 590k | 68.16 |
| 2023-12-31 | $39M | 618k | 62.60 |
| 2023-09-30 | $27M | 586k | 45.39 |
| 2023-06-30 | $32M | 577k | 56.14 |
| 2023-03-31 | $29M | 630k | 45.23 |
| 2022-12-31 | $29M | 715k | 40.65 |
| 2022-09-30 | $44M | 667k | 65.35 |
| 2022-06-30 | $36M | 591k | 60.77 |
| 2022-03-31 | $39M | 614k | 62.77 |
| 2021-12-31 | $45M | 593k | 75.78 |
| 2021-09-30 | $75M | 666k | 111.93 |
| 2021-06-30 | $101M | 624k | 161.89 |
| 2021-03-31 | $68M | 556k | 121.85 |
| 2020-12-31 | $86M | 563k | 153.11 |
| 2020-09-30 | $48M | 572k | 83.64 |
| 2020-06-30 | $37M | 499k | 73.49 |
| 2020-03-31 | $6.9M | 163k | 42.41 |
| 2019-12-31 | $1.2M | 20k | 60.91 |
| 2019-09-30 | $826k | 20k | 40.97 |
More positions owned by Norges Bank Investment Management
View all positions for Norges Bank Investment Management